Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Assessment of structural commonality between tetrahydrocannabinol and anandamide.

Martin BR, Jefferson RG, Winckler R, Wiley JL, Thomas BF, Crocker PJ, Williams W, Razdan RK.

Eur J Pharmacol. 2002 Jan 18;435(1):35-42.

PMID:
11790376
2.

Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.

Di Marzo V, Bisogno T, De Petrocellis L, Brandi I, Jefferson RG, Winckler RL, Davis JB, Dasse O, Mahadevan A, Razdan RK, Martin BR.

Biochem Biophys Res Commun. 2001 Feb 23;281(2):444-51.

PMID:
11181068
3.

Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects.

Wiley JL, Dewey MA, Jefferson RG, Winckler RL, Bridgen DT, Willoughby KA, Martin BR.

Life Sci. 2000 Aug 18;67(13):1573-83.

PMID:
10983852
4.

Cannabinoid properties of methylfluorophosphonate analogs.

Martin BR, Beletskaya I, Patrick G, Jefferson R, Winckler R, Deutsch DG, Di Marzo V, Dasse O, Mahadevan A, Razdan RK.

J Pharmacol Exp Ther. 2000 Sep;294(3):1209-18.

PMID:
10945879
5.

Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.

Martin BR, Jefferson R, Winckler R, Wiley JL, Huffman JW, Crocker PJ, Saha B, Razdan RK.

J Pharmacol Exp Ther. 1999 Sep;290(3):1065-79.

PMID:
10454479
6.

[Asymptomatic chronic-persisting hepatitis B in a young child as source of infection of hepatitis B within a family (author's transl)].

Schober A, Manthei U, Kaboth U, Winckler R, Biswas R, Gerlich W, Hierholzer E, Stamm B.

Dtsch Med Wochenschr. 1978 Apr 7;103(14):623-6. German.

PMID:
639697

Supplemental Content

Loading ...
Support Center